We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease (MUSTARDD-PD)

This study has been terminated.
(Due to low recruitment)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01014858
First Posted: November 17, 2009
Last Update Posted: September 22, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
University of Newcastle Upon-Tyne
University of Cambridge
University of Manchester
University of Birmingham
Bangor University
London School of Economics and Political Science
University College, London
Lancashire Care NHS Foundation Trust
Newcastle University
King's College London
Information provided by (Responsible Party):
Newcastle-upon-Tyne Hospitals NHS Trust
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)